微小 RNA let-7c 通过调节前列腺癌细胞中的 Myc 表达来抑制雄激素受体的表达和活性。
MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
机构信息
Department of Urology, University of California at Davis, Sacramento, California 95817, USA.
出版信息
J Biol Chem. 2012 Jan 6;287(2):1527-37. doi: 10.1074/jbc.M111.278705. Epub 2011 Nov 28.
Abstract
Castration-resistant prostate cancer continues to rely on androgen receptor (AR) expression. AR plays a central role in the development of prostate cancer and progression to castration resistance during and after androgen deprivation therapy. Here, we identified miR-let-7c as a key regulator of expression of AR. miR-let-7c suppresses AR expression and activity in human prostate cancer cells by targeting its transcription via c-Myc. Suppression of AR by let-7c leads to decreased cell proliferation of human prostate cancer cells. Down-regulation of Let-7c in prostate cancer specimens is inversely correlated with AR expression, whereas the expression of Lin28 (a repressor of let-7) is correlated positively with AR expression. Our study demonstrates that the miRNA let-7c plays an important role in the regulation of androgen signaling in prostate cancer by down-regulating AR expression. These results suggest that reconstitution of miR-let-7c may aid in targeting enhanced and hypersensitive AR in advanced prostate cancer.
摘要
去势抵抗性前列腺癌仍然依赖于雄激素受体 (AR) 的表达。AR 在前列腺癌的发生和去势治疗后的进展中发挥着核心作用。在这里，我们确定了 miR-let-7c 是 AR 表达的关键调节因子。miR-let-7c 通过靶向其转录物 c-Myc 来抑制人前列腺癌细胞中 AR 的表达和活性。Let-7c 对 AR 的抑制作用导致人前列腺癌细胞增殖减少。前列腺癌标本中 Let-7c 的下调与 AR 表达呈负相关，而 Lin28（let-7 的抑制物）的表达与 AR 表达呈正相关。我们的研究表明，miRNA let-7c 通过下调 AR 表达在前列腺癌中调节雄激素信号转导方面发挥着重要作用。这些结果表明，miR-let-7c 的再构成可能有助于靶向晚期前列腺癌中增强和超敏的 AR。
相似文献
1
MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.微小 RNA let-7c 通过调节前列腺癌细胞中的 Myc 表达来抑制雄激素受体的表达和活性。
J Biol Chem. 2012 Jan 6;287(2):1527-37. doi: 10.1074/jbc.M111.278705. Epub 2011 Nov 28.
2
MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth.微小 RNA let-7c 在前列腺癌中下调，抑制前列腺癌生长。
PLoS One. 2012;7(3):e32832. doi: 10.1371/journal.pone.0032832. Epub 2012 Mar 30.
3
Conversion of androgen receptor signaling from a growth suppressor in normal prostate epithelial cells to an oncogene in prostate cancer cells involves a gain of function in c-Myc regulation.雄激素受体信号从正常前列腺上皮细胞中的生长抑制因子转变为前列腺癌细胞中的致癌基因，这一过程涉及c-Myc调控功能的获得。
Int J Biol Sci. 2014 Jun 10;10(6):627-42. doi: 10.7150/ijbs.8756. eCollection 2014.
4
NDRG2 acts as a negative regulator downstream of androgen receptor and inhibits the growth of androgen-dependent and castration-resistant prostate cancer.NDRG2作为雄激素受体下游的负调节因子，抑制雄激素依赖性和去势抵抗性前列腺癌的生长。
Cancer Biol Ther. 2015;16(2):287-96. doi: 10.1080/15384047.2014.1002348.
5
NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer.NF-κB2/p52:c-Myc:hnRNPA1通路调控前列腺癌中雄激素受体剪接变体的表达及恩杂鲁胺敏感性
Mol Cancer Ther. 2015 Aug;14(8):1884-95. doi: 10.1158/1535-7163.MCT-14-1057. Epub 2015 Jun 8.
6
Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening.通过互补功能微小RNA文库筛选鉴定miR-30b-3p和miR-30d-5p为前列腺癌中雄激素受体信号通路的直接调节因子。
Oncotarget. 2016 Nov 8;7(45):72593-72607. doi: 10.18632/oncotarget.12241.
7
Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.前列腺癌中由于雄激素反应丧失导致 Akt 信号转导增加。
Curr Med Chem. 2013;20(1):144-57.
8
TCF7 is suppressed by the androgen receptor via microRNA-1-mediated downregulation and is involved in the development of resistance to androgen deprivation in prostate cancer.TCF7通过微小RNA-1介导的下调被雄激素受体抑制，并参与前列腺癌对雄激素剥夺的抗性发展。
Prostate Cancer Prostatic Dis. 2017 Jun;20(2):172-178. doi: 10.1038/pcan.2017.2. Epub 2017 Feb 21.
9
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity.MEIS1 通过 MYC 的下调介导前列腺癌的发展，通过提高 HOXB13 的表达和 AR 的活性。
Oncogene. 2020 Aug;39(34):5663-5674. doi: 10.1038/s41388-020-01389-7. Epub 2020 Jul 17.
10
Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.全面蛋白质组分析确定雄激素受体轴和其他信号通路是转移性前列腺癌中被抑制的微小RNA的作用靶点。
Oncogene. 2016 May 5;35(18):2345-56. doi: 10.1038/onc.2015.295. Epub 2015 Sep 14.
引用本文的文献
1
LIN 28B expression is downregulated in mature spermatozoa of oligozoospermic men and associates with genetic variants previously linked to pubertal onset.LIN 28B在少精子症男性的成熟精子中表达下调，并与先前与青春期启动相关的基因变异有关。
Endocr Connect. 2025 May 28;14(6). doi: 10.1530/EC-25-0044. Print 2025 Jun 1.
2
The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases.金丝桃苷的多种生物学活性：从分子机制到肿瘤和非肿瘤疾病的治疗前景
Front Pharmacol. 2025 Mar 3;16:1538601. doi: 10.3389/fphar.2025.1538601. eCollection 2025.
3
miRNAs Dysregulated in Human Papillomavirus-Associated Benign Prostatic Lesions and Prostate Cancer.在人乳头瘤病毒相关的良性前列腺病变和前列腺癌中失调的微小RNA
Cancers (Basel). 2024 Dec 25;17(1):26. doi: 10.3390/cancers17010026.
4
Prostatic androgen receptor signaling shows an age-related and lobe-specific alteration in mice.前列腺雄激素受体信号传导在小鼠中表现出与年龄相关的叶特异性改变。
Sci Rep. 2024 Dec 5;14(1):30302. doi: 10.1038/s41598-024-79879-x.
5
Role of non-coding RNA in lineage plasticity of prostate cancer.非编码RNA在前列腺癌谱系可塑性中的作用。
Cancer Gene Ther. 2025 Jan;32(1):1-10. doi: 10.1038/s41417-024-00834-z. Epub 2024 Nov 4.
6
AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.由NF-κB和p38丝裂原活化蛋白激酶信号介导的前列腺癌基质中的雄激素受体缺失会破坏基质形态发生素的产生。
Oncogene. 2024 Jun;43(27):2092-2103. doi: 10.1038/s41388-024-03064-7. Epub 2024 May 20.
7
Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent.使用小分子配体和内体逃逸剂将化学修饰的miR-34a选择性靶向前列腺癌。
Mol Ther Nucleic Acids. 2024 Apr 23;35(2):102193. doi: 10.1016/j.omtn.2024.102193. eCollection 2024 Jun 11.
8
ER Negative Breast Cancer and miRNA: There Is More to Decipher Than What the Pathologist Can See!雌激素受体阴性乳腺癌与微小RNA：需要解读的内容远不止病理学家所能看到的！
Biomedicines. 2023 Aug 18;11(8):2300. doi: 10.3390/biomedicines11082300.
9
MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer.微小RNA作为前列腺癌诊断、预后及治疗的临床工具
Transl Oncol. 2023 Feb;28:101613. doi: 10.1016/j.tranon.2022.101613. Epub 2023 Jan 4.
10
Lin28 Regulates Cancer Cell Stemness for Tumour Progression.Lin28调控癌细胞干性以促进肿瘤进展。
Cancers (Basel). 2022 Sep 24;14(19):4640. doi: 10.3390/cancers14194640.
本文引用的文献
1
Androgen regulation of gene expression.雄激素对基因表达的调控。
Adv Cancer Res. 2010;107:137-62. doi: 10.1016/S0065-230X(10)07005-3.
2
Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells.雄激素受体在前列腺癌细胞中由 NF-kappaB2/p52 异常激活。
Cancer Res. 2010 Apr 15;70(8):3309-19. doi: 10.1158/0008-5472.CAN-09-3703. Epub 2010 Apr 13.
3
Lin28: A microRNA regulator with a macro role.Lin28：一个具有重要作用的 microRNA 调节因子。
Cell. 2010 Feb 19;140(4):445-9. doi: 10.1016/j.cell.2010.02.007.
4
Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer.前列腺癌中肌动蛋白相关蛋白转胶蛋白（SM22）的表达减少。
Cell Tissue Res. 2010 Feb;339(2):337-47. doi: 10.1007/s00441-009-0902-y. Epub 2009 Dec 11.
5
An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.一种涉及核因子-κB、Lin28、Let-7微小RNA和白细胞介素6的表观遗传开关将炎症与细胞转化联系起来。
Cell. 2009 Nov 13;139(4):693-706. doi: 10.1016/j.cell.2009.10.014. Epub 2009 Oct 29.
6
Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.微阵列分析揭示 NF-kappaB2/p52 在 LNCaP 前列腺癌细胞中的潜在靶基因。
Prostate. 2010 Feb 15;70(3):276-87. doi: 10.1002/pros.21062.
7
The role of let-7 in cell differentiation and cancer.Let-7 在细胞分化和癌症中的作用。
Endocr Relat Cancer. 2010 Jan 29;17(1):F19-36. doi: 10.1677/ERC-09-0184. Print 2010 Mar.
8
MicroRNAs and prostate cancer.微小 RNA 与前列腺癌。
Endocr Relat Cancer. 2010 Jan 29;17(1):F1-17. doi: 10.1677/ERC-09-0172. Print 2010 Mar.
9
From pathogenesis to prevention of castration resistant prostate cancer.从去势抵抗性前列腺癌的发病机制到预防
Prostate. 2010 Jan 1;70(1):100-12. doi: 10.1002/pros.21042.
10
Towards the definition of prostate cancer-related microRNAs: where are we now?迈向前列腺癌相关微小RNA的定义：我们目前进展如何？
Trends Mol Med. 2009 Sep;15(9):381-90. doi: 10.1016/j.molmed.2009.07.004. Epub 2009 Aug 27.
Zotero 插件